TEVA
Teva Pharmaceutical Industries Ltd Earnings
$17.61
Earnings Summary
Revenue | $4176Mn |
Net Profits | $282Mn |
Net Profit Margins | 6.75% |
Teva Pharmaceutical Industries Ltd’s revenue jumped 0.34% since last year same period to $4176Mn in the Q2 2025. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 7.32% jump in its revenue since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit jumped 133.37% since last year same period to $282Mn in the Q2 2025. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 31.78% jump in its net profits since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit margin jumped 133.26% since last year same period to 6.75% in the Q2 2025. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 22.78% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.69 |
EPS Estimate Current Year | 0.69 |
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current quarter stand at 0.69 - a 9.52% jump from last quarter’s estimates.
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current year stand at 0.69.
Key Ratios
Earning Per Share (EPS) | 0 |
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Teva Pharmaceutical Industries Ltd has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-06 | 0.69 | 0 | -100% |
2025-07-30 | 0.63 | 0.66 | 4.76% |
2025-05-07 | 0.46 | 0.52 | 12.19% |
